A phase II study of erlotinib and bevacizumab in patients with locally advanced and/or metastatic (stage IIIB or IV) non-small cell lung cancer who have not received prior chemotherapy.
Phase of Trial: Phase II
Latest Information Update: 16 Sep 2011
At a glance
- Drugs Bevacizumab; Erlotinib
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 16 Sep 2011 Last checked against ISRCTN: Current Controlled Trials.
- 16 Dec 2010 New source identified and integrated (Netherlands Trial Register, 1049373).
- 06 Jun 2007 Status change to completed.